Emergent BioSolutions (EBS) Gross Profit (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Gross Profit of $84.1 million for Q1 2026, down 37.1% year-over-year from $133.7 million in Q1 2025, and up 31.82% quarter-over-quarter from $63.8 million in Q4 2025.
Emergent BioSolutions (EBS) Gross Profit (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Gross Profit history runs 16 years deep, the most recent figure standing at $84.1 million for Q1 2026.
- In Q1 2026, Gross Profit fell 37.1% year-over-year to $84.1 million; the TTM figure through Mar 2026 stood at $367.1 million (down 3.8% YoY), while the FY2025 annual figure was $416.7 million, up 15.02% from the prior year.
- Gross Profit for Q1 2026 stood at $84.1 million, up from $63.8 million in the prior quarter.
- The five-year high for Gross Profit was $224.5 million in Q1 2022, with the low at $11.4 million in Q1 2023.
- The 5-year median for Gross Profit is $113.7 million (2023), against an average of $118.2 million.
- The sharpest annual moves came in 2023 and 2024: Gross Profit slumped 94.92% in 2023, then soared 1266.67% in 2024.
- Emergent BioSolutions' Gross Profit stood at $162.9 million in 2022, then sank by 43.83% to $91.5 million in 2023, then slipped by 16.17% to $76.7 million in 2024, then fell by 16.82% to $63.8 million in 2025, then soared by 31.82% to $84.1 million in 2026.
- Business Quant data shows EBS's Gross Profit at $84.1 million in Q1 2026, $63.8 million in Q4 2025, and $145.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 137.20 Mn |
| Jun 30, 2026 | 137.20 Mn |
| Mar 31, 2026 | 84.10 Mn |
| Mar 31, 2026 | 84.10 Mn |
| Dec 31, 2025 | 63.80 Mn |
| Dec 31, 2025 | 63.80 Mn |
| Sep 30, 2025 | 145.20 Mn |
| Sep 30, 2025 | 145.20 Mn |
| Jun 30, 2025 | 74.00 Mn |
| Jun 30, 2025 | 74.00 Mn |
| Mar 31, 2025 | 133.70 Mn |
| Mar 31, 2025 | 133.70 Mn |
| Dec 31, 2024 | 76.70 Mn |
| Dec 31, 2024 | 76.70 Mn |
| Sep 30, 2024 | 171.20 Mn |
| Sep 30, 2024 | 171.20 Mn |
| Mar 31, 2024 | 155.80 Mn |
| Mar 31, 2024 | 155.80 Mn |
| Dec 31, 2023 | 91.50 Mn |
| Dec 31, 2023 | 91.50 Mn |